静脉注射氨甲环酸能否减少全阴道封闭术时的出血量?一项随机双盲安慰剂对照试验
本研究为双盲随机安慰剂对照试验,纳入30例接受全阴道封闭术(±中段尿道悬吊术)的子宫切除术后盆腔器官脱垂女性,随机给予单次1克静脉氨甲环酸或安慰剂。结果显示两组在血红蛋白、血细胞比容及术中出血量等出血结局上均无显著差异,氨甲环酸组无显著不良事件。
要点
- 全阴道封闭术时单次静脉氨甲环酸1克与安慰剂相比,出血结局无显著差异。
- 氨甲环酸组1例因临床显著贫血于术后1天接受输血。
- 氨甲环酸组未发生与研究干预相关的显著不良事件。
核心结论
- 全阴道封闭术(±中段尿道悬吊术)时使用静脉氨甲环酸在出血结局上无统计学显著差异。
- 氨甲环酸给药虽无出血方面的优势,但未显示显著不良效应。
- 本研究强化了在全阴道封闭术时审慎使用氨甲环酸而非预防性使用的观点。
研究设计与样本
- 双盲、随机、安慰剂对照试验。
- 研究场所为三级学术泌尿妇科 practice。
- 30名接受全阴道封闭术(±中段尿道悬吊术)治疗子宫切除术后盆腔器官脱垂的女性完成研究(氨甲环酸组14例;安慰剂组16例)。
- 参与者于麻醉诱导后随机接受单次1克氨甲环酸或安慰剂。
主要发现
- 主要结局术前与术后24小时血红蛋白和血细胞比容差值组间无显著差异:血红蛋白差值氨甲环酸组3.2g/dL vs 安慰剂组2.6g/dL,P=0.41;血细胞比容差值氨甲环酸组0.09 vs 安慰剂组0.08,P=0.25。
- 术中出血量氨甲环酸组340mL vs 安慰剂组405mL,P=0.58。
- 氨甲环酸组1例患者因临床显著贫血于术后1天接受输血。
- 氨甲环酸组未发生与研究干预相关的显著不良事件。
- 安全性结局于术后6周评估。
临床怎么用
- 作者认为,本研究结果强化了在全阴道封闭术时审慎使用氨甲环酸而非预防性使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To determine the efficacy of intravenous (IV) tranexamic acid (TXA) in reducing blood loss and blood transfusion among women undergoing total colpocleisis. DESIGN: Double-blind, randomized, placebo-controlled trial. SETTING: Tertiary academic urogynecology practice. PARTICIPANTS: Consenting women undergoing total colpocleisis (±midurethral sling) for treatment of posthysterectomy pelvic organ prolapse. INTERVENTIONS: Participants were randomly assigned to a single dose of 1gram TXA or placebo after anesthesia induction. Primary outcome measures were the differences in preoperative hemoglobin (hgb) and hematocrit (hct) compared to those measured 24 hours after surgery. Secondary outcomes included the difference in intraoperative blood loss and the need for blood transfusion during hospital stay. Safety outcomes were assessed 6 weeks postoperatively. MAIN RESULTS: Thirty participants completed the study (TXA: 14; placebo: 16). Preoperative variables were similar between groups. Intraoperative outcomes were also comparable, and all surgeries were completed under general anesthesia. No significant differences were observed in any blood loss outcomes between groups (TXA versus placebo differences: hgb 3.2g/dL versus 2.6g/dL, p = .41; hct 0.09 versus 0.08, p = .25; intraoperative blood loss 340mL versus 405mL, p = .58). One patient in the TXA group received a blood transfusion 1 day after surgery due to medically significant anemia. There were no significant adverse events related to the study intervention in the TXA group. CONCLUSION: This study showed no statistically significant differences in blood loss outcomes with the use of IV TXA at the time of total colpocleisis (±midurethral sling). While TXA administration showed no advantage regarding blood loss, it demonstrated no significant adverse effects. This study reinforces judicious use of TXA at the time of colpocleisis rather than using it prophylactically.
引用
- McDermott CD, Lovatsis D, Wang S, et al. Does Intravenous Tranexamic Acid Reduce Blood Loss at the Time of Total Colpocleisis? A Randomized Double-Blind Placebo-Controlled Trial. J Minim Invasive Gynecol. 2025. PMID: 39814219. doi:10.1016/j.jmig.2025.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。